Global Nuclear Medicine-Radiopharmaceuticals Sales Market Report 2016

November 2016 | 115 pages | ID: GCA2EEC229DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Nuclear Medicine-Radiopharmaceuticals

Revenue, means the sales value of Nuclear Medicine-Radiopharmaceuticals

This report studies sales (consumption) of Nuclear Medicine-Radiopharmaceuticals in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Cardinal Health, Inc (US)
• GE Healthcare (UK)
• Bracco Imaging S.p.A (Italy)
• Nordion, Inc. (Canada)
• Bayer HealthCare Medical Care (US)
• Lantheus Medical Imaging Inc (US)
• Advanced Medical Isotope Corporation (US)
• Alliance Medical (UK)
• Alseres Pharmaceuticals, Inc (US)
• Avid Radiopharmaceuticals (US)
• Actinium Pharmaceuticals Inc (US)
• Ion Beam Applications S.A (Belgium)
• Immunomedics, Inc. (US)
• Jubilant Pharma (India)
• Mallinckrodt Pharmaceuticals (Ireland)
• Medi-Radiopharma Ltd (Hungary)
• Peregrine Pharmaceuticals, Inc. (US)
• Siemens Healthcare (US)
• Positron Corporation (US)
• Triad Isotopes, Inc. (US)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Nuclear Medicine-Radiopharmaceuticals in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
• Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Nuclear Medicine-Radiopharmaceuticals in each application, can be divided into

• Diagnostic Applications: SPECT, PET.
• Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
• Application 3

Contents

Global Nuclear Medicine-Radiopharmaceuticals Sales Market Report 2016

1 NUCLEAR MEDICINE-RADIOPHARMACEUTICALS OVERVIEW

1.1 Product Overview and Scope of Nuclear Medicine-Radiopharmaceuticals
1.2 Classification of Nuclear Medicine-Radiopharmaceuticals
  1.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
  1.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
  1.2.3 Type III
1.3 Application of Nuclear Medicine-Radiopharmaceuticals
  1.3.1 Diagnostic Applications: SPECT, PET.
  1.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
  1.3.3 Application
1.4 Nuclear Medicine-Radiopharmaceuticals Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Nuclear Medicine-Radiopharmaceuticals (2011-2021)
  1.5.1 Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2021)
  1.5.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)

2 GLOBAL NUCLEAR MEDICINE-RADIOPHARMACEUTICALS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Nuclear Medicine-Radiopharmaceuticals Market Competition by Manufacturers
  2.1.1 Global Nuclear Medicine-Radiopharmaceuticals Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Share by Manufacturers (2011-2016)
2.2 Global Nuclear Medicine-Radiopharmaceuticals (Volume and Value) by Type
  2.2.1 Global Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type (2011-2016)
  2.2.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2011-2016)
2.3 Global Nuclear Medicine-Radiopharmaceuticals (Volume and Value) by Regions
  2.3.1 Global Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Regions (2011-2016)
2.4 Global Nuclear Medicine-Radiopharmaceuticals (Volume) by Application

3 UNITED STATES NUCLEAR MEDICINE-RADIOPHARMACEUTICALS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)
  3.1.1 United States Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
  3.1.2 United States Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
  3.1.3 United States Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
3.2 United States Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers
3.3 United States Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type
3.4 United States Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

4 CHINA NUCLEAR MEDICINE-RADIOPHARMACEUTICALS (VOLUME, VALUE AND SALES PRICE)

4.1 China Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)
  4.1.1 China Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
  4.1.2 China Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
  4.1.3 China Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
4.2 China Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers
4.3 China Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type
4.4 China Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

5 EUROPE NUCLEAR MEDICINE-RADIOPHARMACEUTICALS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)
  5.1.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
  5.1.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
5.2 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers
5.3 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type
5.4 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

6 JAPAN NUCLEAR MEDICINE-RADIOPHARMACEUTICALS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)
  6.1.1 Japan Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
  6.1.2 Japan Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
6.2 Japan Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers
6.3 Japan Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type
6.4 Japan Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

7 GLOBAL NUCLEAR MEDICINE-RADIOPHARMACEUTICALS MANUFACTURERS ANALYSIS

7.1 Cardinal Health, Inc (US)
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 GE Healthcare (UK)
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 115 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Bracco Imaging S.p.A (Italy)
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 135 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Nordion, Inc. (Canada)
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Nov Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Bayer HealthCare Medical Care (US)
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Lantheus Medical Imaging Inc (US)
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Advanced Medical Isotope Corporation (US)
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Alliance Medical (UK)
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Alseres Pharmaceuticals, Inc (US)
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Avid Radiopharmaceuticals (US)
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Actinium Pharmaceuticals Inc (US)
7.12 Ion Beam Applications S.A (Belgium)
7.13 Immunomedics, Inc. (US)
7.14 Jubilant Pharma (India)
7.15 Mallinckrodt Pharmaceuticals (Ireland)
7.16 Medi-Radiopharma Ltd (Hungary)
7.17 Peregrine Pharmaceuticals, Inc. (US)
7.18 Siemens Healthcare (US)
7.19 Positron Corporation (US)
7.20 Triad Isotopes, Inc. (US)

8 NUCLEAR MEDICINE-RADIOPHARMACEUTICALS MAUFACTURING COST ANALYSIS

8.1 Nuclear Medicine-Radiopharmaceuticals Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Nuclear Medicine-Radiopharmaceuticals Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NUCLEAR MEDICINE-RADIOPHARMACEUTICALS MARKET FORECAST (2016-2021)

12.1 Global Nuclear Medicine-Radiopharmaceuticals Sales, Revenue Forecast (2016-2021)
12.2 Global Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Regions (2016-2021)
12.3 Global Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Type (2016-2021)
12.4 Global Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Application (2016-2021)

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nuclear Medicine-Radiopharmaceuticals
Table Classification of Nuclear Medicine-Radiopharmaceuticals
Figure Global Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Type in 2015
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Picture
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Picture
Table Applications of Nuclear Medicine-Radiopharmaceuticals
Figure Global Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Application in 2015
Figure Diagnostic Applications: SPECT, PET. Examples
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Examples
Figure United States Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Figure China Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2021)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales of Key Manufacturers (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Share by Manufacturers (2011-2016)
Figure 2015 Nuclear Medicine-Radiopharmaceuticals Sales Share by Manufacturers
Figure 2016 Nuclear Medicine-Radiopharmaceuticals Sales Share by Manufacturers
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue by Manufacturers (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers
Table 2016 Global Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers
Table Global Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Share by Type (2011-2016)
Figure Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Type (2011-2016)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales Growth Rate by Type (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Nuclear Medicine-Radiopharmaceuticals by Type (2011-2016)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue Growth Rate by Type (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Regions (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Share by Regions (2011-2016)
Figure Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Regions (2011-2016)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales Growth Rate by Regions (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Regions (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Nuclear Medicine-Radiopharmaceuticals by Regions (2011-2016)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue Growth Rate by Regions (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application (2011-2016)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Share by Application (2011-2016)
Figure Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Application (2011-2016)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales Growth Rate by Application (2011-2016)
Figure United States Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
Figure United States Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
Figure United States Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2011-2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2011-2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Sales by Type (2011-2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2011-2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Sales by Application (2011-2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2011-2016)
Figure China Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
Figure China Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
Figure China Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
Table China Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2011-2016)
Table China Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2011-2016)
Table China Nuclear Medicine-Radiopharmaceuticals Sales by Type (2011-2016)
Table China Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2011-2016)
Table China Nuclear Medicine-Radiopharmaceuticals Sales by Application (2011-2016)
Table China Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2011-2016)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales by Type (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales by Application (2011-2016)
Table Europe Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2011-2016)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)
Table Japan Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2011-2016)
Table Japan Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2011-2016)
Table Japan Nuclear Medicine-Radiopharmaceuticals Sales by Type (2011-2016)
Table Japan Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2011-2016)
Table Japan Nuclear Medicine-Radiopharmaceuticals Sales by Application (2011-2016)
Table Japan Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2011-2016)
Table Cardinal Health, Inc (US) Basic Information List
Table Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table GE Healthcare (UK) Basic Information List
Table GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Bracco Imaging S.p.A (Italy) Basic Information List
Table Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Nordion, Inc. (Canada) Basic Information List
Table Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Bayer HealthCare Medical Care (US) Basic Information List
Table Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Lantheus Medical Imaging Inc (US) Basic Information List
Table Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Advanced Medical Isotope Corporation (US) Basic Information List
Table Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Alliance Medical (UK) Basic Information List
Table Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Alseres Pharmaceuticals, Inc (US) Basic Information List
Table Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Avid Radiopharmaceuticals (US) Basic Information List
Table Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Actinium Pharmaceuticals Inc (US) Basic Information List
Table Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Ion Beam Applications S.A (Belgium) Basic Information List
Table Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Immunomedics, Inc. (US) Basic Information List
Table Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Jubilant Pharma (India) Basic Information List
Table Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Mallinckrodt Pharmaceuticals (Ireland) Basic Information List
Table Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Medi-Radiopharma Ltd (Hungary) Basic Information List
Table Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Peregrine Pharmaceuticals, Inc. (US) Basic Information List
Table Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Siemens Healthcare (US) Basic Information List
Table Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Positron Corporation (US) Basic Information List
Table Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Triad Isotopes, Inc. (US) Basic Information List
Table Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals
Figure Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals
Figure Nuclear Medicine-Radiopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015
Table Major Buyers of Nuclear Medicine-Radiopharmaceuticals
Table Distributors/Traders List
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Regions (2016-2021)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Type (2016-2021)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Application (2016-2021)